NovoCure Balance Sheet
NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NovoCure financial position
At the end of fiscal 2025, NovoCure reported total assets of $804.3 million, down 35.2% from a year earlier against total liabilities of $463.9 million. Shareholders' equity stood at $340.5 million, or 42.3% of assets. The company held $93.5 million in cash and equivalents against $195.0 million of debt, a net debt position of $101.5 million.
The current ratio (current assets divided by current liabilities) was 2.90, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.57.
Summary generated from market data by MetaCap's automated system. Methodology
NovoCure balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 93.55M | 163.77M | 240.82M | 115.33M | 208.80M | 234.67M | 177.32M | 140.62M | 78.59M | 99.78M |
| Receivables | 89.44M | 74.23M | 61.22M | 86.26M | 93.57M | 96.70M | 58.86M | 36.52M | 29.57M | 6.34M |
| Inventory | 41.11M | 35.09M | 38.15M | 29.38M | 24.43M | 27.42M | 23.70M | 22.55M | 22.02M | 25.55M |
| Total Current Assets | 646.73M | 1.11B | 1.03B | 1.11B | 1.07B | 999.44M | 439.95M | 321.37M | 245.13M | 261.87M |
| Property, Plant & Equipment | 77.61M | 77.66M | 51.48M | 32.68M | 22.69M | 11.39M | 9.34M | 8.44M | 9.03M | 9.81M |
| Total Assets | 804.33M | 1.24B | 1.15B | 1.19B | 1.14B | 1.05B | 479.45M | 339.79M | 265.30M | 282.08M |
| Accounts Payable | 122.23M | 105.09M | 94.39M | 85.20M | 72.60M | 53.65M | 36.92M | 26.71M | 17.21M | 18.36M |
| Short-Term Debt | — | — | — | — | — | — | — | 31.00K | 32.00K | 70.00K |
| Total Current Liabilities | 223.23M | 756.39M | 179.12M | 158.78M | 142.60M | 113.61M | 86.31M | 64.56M | 50.20M | 36.88M |
| Long-Term Debt | 195.05M | 97.30M | 568.82M | 565.51M | 562.22M | 429.90M | 149.42M | 149.27M | 97.34M | 96.23M |
| Total Liabilities | 463.86M | 880.61M | 783.63M | 750.48M | 729.00M | 575.46M | 261.66M | 227.53M | 151.73M | 139.74M |
| Shareholders' Equity | 340.47M | 360.18M | 362.50M | 441.17M | 410.49M | 476.53M | 217.79M | 112.26M | 113.56M | 142.34M |
| Retained Earnings | -1.29B | -1.15B | -985.50M | -778.46M | -685.93M | -631.08M | -650.88M | -643.65M | -582.26M | -519.93M |
| Total Debt | 195.05M | 97.30M | 568.82M | 565.51M | 562.22M | 429.90M | 149.42M | 149.30M | 97.37M | 96.30M |
| Net Cash (Debt) | -101.50M | 66.47M | -328.00M | -450.18M | -353.41M | -195.23M | 27.90M | -8.68M | -18.78M | 3.48M |
| Shares Outstanding | 112.49M | 108.52M | 107.08M | 105.05M | 103.97M | 102.33M | 99.53M | 93.25M | 89.48M | 87.07M |
This table shows 10 annual periods of NovoCure's balance sheet, from FY 2025 back to FY 2016, across 16 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow NVCR's reporting calendar. What is a balance sheet?